The Impact Of Declining Dental Needs Of Age Cohorts On The Cost-effectiveness Of Water Fluoridation & Supplementary Prev
Funder
National Health and Medical Research Council
Funding Amount
$85,600.00
Summary
This research will apply economic modelling, based on current trend-data by birth cohort on the effectiveness of water fluoridation to the evaluation of its continuing application to metropolitan water supplies. Wherever possible data from Victoria, and Australia as a whole, will be used in the modelling. It will explore the implications for policy-making in relation to maintenance of benefits gained and potential future application to non-fluoridated rural water supplies in Victoria. A key focu ....This research will apply economic modelling, based on current trend-data by birth cohort on the effectiveness of water fluoridation to the evaluation of its continuing application to metropolitan water supplies. Wherever possible data from Victoria, and Australia as a whole, will be used in the modelling. It will explore the implications for policy-making in relation to maintenance of benefits gained and potential future application to non-fluoridated rural water supplies in Victoria. A key focus is to identify and analyse data relating to the point at which there is a ‘plateauing-out’ of the benefits accruing from water fluoridation in middle and older age. The evaluation will also consider the policy implications of trends towards retention of more teeth into older age and the consequent increased exposure to both caries and periodontal disease.Read moreRead less
Novel System For Non-Invasive Delivery Of Drugs To The Interior Of The Eye
Funder
National Health and Medical Research Council
Funding Amount
$200,213.00
Summary
Age-related macular degeneration (AMD) is the leading cause of visual loss for adults in the developed world. Treatment is now by needle injection into the back of the eye, which is painful for the patient and is costly for the health-care system. Seagull Technology Pty Ltd has developed a non-invasive device for treating the back of the eye without the need for a needle injection. This project will test the new device in animals and then move to a first safety study for human AMD patients.